2021
DOI: 10.1016/j.ophtha.2020.08.033
|View full text |Cite
|
Sign up to set email alerts
|

Value of 10-2 Visual Field Testing in Glaucoma Patients with Early 24-2 Visual Field Loss

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
19
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 25 publications
2
19
1
Order By: Relevance
“…Identification of central visual field defects is possible using sparse test grids (24-2 and 24-2C), even if a traditional "cluster" criterion cannot be met, which could then signal the clinician to perform additional focussed central testing. 12,13,18,40,41 The 10 extra locations tested by the 24-2C grid are derived from the same Cartesian coordinates of the 10-2 grid.…”
Section: Test Density and Sampling For Identifying Contiguous Points mentioning
confidence: 99%
See 1 more Smart Citation
“…Identification of central visual field defects is possible using sparse test grids (24-2 and 24-2C), even if a traditional "cluster" criterion cannot be met, which could then signal the clinician to perform additional focussed central testing. 12,13,18,40,41 The 10 extra locations tested by the 24-2C grid are derived from the same Cartesian coordinates of the 10-2 grid.…”
Section: Test Density and Sampling For Identifying Contiguous Points mentioning
confidence: 99%
“…Despite the advantages afforded by the higher resolution 10-2 grid, recent studies have offered contrarian views on its additional usefulness compared to the 24-2. 12,13 A question for clinicians is which test to deploy in routine glaucoma assessments, as both central and peripheral tests may provide useful information for the individual patient, depending on their phenotype. Simultaneously performing testing using both grids may be valuable in comprehensively characterising the visual field with the complementary regions of testing.…”
Section: J O U R N a L P R E -P R O O F Introductionmentioning
confidence: 99%
“…IOP was not considered for the diagnosis, and all 21 eyes had gonioscopically open anterior chamber angles. Optic disk damage was evaluated with Spectralis optical coherence tomography (Heidelberg Engineering Inc., Heidelberg, Germany), and visual field examinations were performed using Humphrey automated perimetry (24-2 Swedish Interactive Threshold Algorithm standard [20]; Humphrey Visual Field Analyzer; Carl Zeiss Meditec, Inc., Dublin, CA). This study followed the tenets of the Declaration of Helsinki and was approved by the local Ethical Committee of Biomedical Research.…”
Section: Participantsmentioning
confidence: 99%
“…These findings are consistent with previous studies. 13,14 Glaucoma affects both central and midperipheral vision. Patients with CVFDs would have greater impairment in visual function than those with the preserved central VF.…”
Section: Discussionmentioning
confidence: 99%
“…13 Yet, they have suggested 10-2 to 24-2 testing for detecting progressive paracentral field loss and functional progression, particularly in eyes with any abnormalities within the central 12 points on 24-2 VF. 13,14 The value of detecting a CVFD (defined as the abnormalities within the central 12 points, in the central 10 degrees on 24-2 VF) and related parafoveal scotomas with a 10-2 VF test to document glaucomatous damage to the macula is well recognized. 5,8,15 The macula, the central 8 degrees surrounding fixation, contains ∼40% of all retinal ganglion cells.…”
mentioning
confidence: 99%